∙ Background information on the use of aspirin in cardiovascular diseases; ∙ Description of the clinical equipoise regarding the optimal dose in secondary prevention; ∙ Goals of the ADAPTABLE trial; ∙ Randomization process; ∙ Study outcomes; ∙ Description of participants flow during the study; ∙ Study duration; ∙ Security of personal information; ∙ Side effects of aspirin; ∙ Absence of direct benefits to participate in the trial; ∙ Contact information of the study team. |